{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:10:53Z","timestamp":1773875453331,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":152,"publisher":"Springer New York","isbn-type":[{"value":"9781461406495","type":"print"},{"value":"9781461406501","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-1-4614-0650-1_7","type":"book-chapter","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T10:43:17Z","timestamp":1315651397000},"page":"99-119","source":"Crossref","is-referenced-by-count":52,"title":["Glycosphingolipids and Insulin Resistance"],"prefix":"10.1007","author":[{"given":"Johannes M.","family":"Aerts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf G.","family":"Boot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Groener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Bijl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence M.","family":"Bietrix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert K.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roelof","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"van Roomen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Aten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"Serlie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Wennekes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermen S.","family":"Overkleeft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.physiol.68.040104.124723","volume":"68","author":"SB Biddinger","year":"2006","unstructured":"Biddinger SB, Kahn CR. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 2006; 68:123\u2013158.","journal-title":"Annu Rev Physiol"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1210\/jc.86.3.972","volume":"86","author":"Y Kido","year":"2001","unstructured":"Kido Y, Nakae J, Accili D. Clinical review 125: the insulin receptor and its cellular targets. J Clin Endocrinol Metab 2001; 86:972\u2013979.","journal-title":"J Clin Endocrinol Metab"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1464-5491.2005.01566.x","volume":"22","author":"S Schinner","year":"2005","unstructured":"Schinner S, Scherbaum WA, Bornstein SR et al. Molecular mechanisms of insulin resistance. Diabetic Med 2005; 22:674\u2013682.","journal-title":"Diabetic Med"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S1043-2760(02)00662-8","volume":"13","author":"EL Whiteman","year":"2002","unstructured":"Whiteman EL, Cho H, Birnbaum MJ. Role of Akt\/protein kinase B in metabolism. Trends Endocrinol Metab 2002; 13:444\u2013451.","journal-title":"Trends Endocrinol Metab"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cmet.2008.04.005","volume":"7","author":"KL Hoehn","year":"2008","unstructured":"Hoehn KL, Hohnen-Behrens C, Cederberg A et al. IRS 1-independent defects define major nodes of insulin resistance. Cell Metab 2008; 7:421\u2013433.","journal-title":"Cell Metab"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross DA, Alessi DR, Cohen P et al. Inhibition of glycogen synthasekinase-3 by insulin mediated by protein kinase B. Nature 1995; 378:785\u2013789.","journal-title":"Nature"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.96.13.7421","volume":"96","author":"WH Biggs 3rd","year":"1999","unstructured":"Biggs WH 3rd, Meisenhelder J, Hunter T et al. Protein kinase B\/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factorFKHR1. Proc Natl Acad Sci USA 1999; 96:7421\u20137426.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1101\/gad.12.16.2488","volume":"12","author":"S Paradis","year":"1998","unstructured":"Paradis S, Ruvkun G. Caenorhabditis elegans Akt\/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 1998; 12:2488\u20132498.","journal-title":"Genes Dev"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ncb840","volume":"4","author":"CJ Potter","year":"2002","unstructured":"Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 2002;4:658\u2013665.","journal-title":"Nat Cell Biol"},{"key":"7_CR10","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/MCB.19.9.6286","volume":"19","author":"T Kitamura","year":"1999","unstructured":"Kitamura T, Kitamura Y, Kuroda S et al. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 1999; 19:6286\u20136296.","journal-title":"Mol Cell Biol"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"22115","DOI":"10.1074\/jbc.C200198200","volume":"277","author":"S Kane","year":"2002","unstructured":"Kane S, Sano H, Liu SC et al. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 2002; 277:22115\u201322118.","journal-title":"J Biol Chem"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1210\/en.2006-1167","volume":"148","author":"L Chang","year":"2007","unstructured":"Chang L, Chiang SH, Saltiel AR. TC10alpha is required for insulin-stimulated glucose uptake in adipocytes. Endocrinology 2007; 148:27\u201333.","journal-title":"Endocrinology"},{"issue":"35","key":"7_CR13","doi-asserted-by":"publisher","first-page":"20801","DOI":"10.1074\/jbc.270.35.20801","volume":"270","author":"DF Lazar","year":"1995","unstructured":"Lazar DF, Wiese RJ, Brady MJ et al. Mitogen-activated protein kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem 1995; 270(35):20801\u201320807.","journal-title":"J Biol Chem"},{"issue":"4","key":"7_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cmet.2008.09.001","volume":"8","author":"AJ Meijer","year":"2008","unstructured":"Meijer AJ, Codogno P. Autophagy: a sweet process in diabetes. Cell Metab 2008; 8(4):275\u2013276.","journal-title":"Cell Metab"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/cdd.2008.101","volume":"16","author":"F Scarlatti","year":"2009","unstructured":"Scarlatti F, Granata R, Meijer AJ et al. Does autophagy have a license to kill mammalian cells? Cell Death Differ 2009; 16:12\u201320.","journal-title":"Cell Death Differ"},{"key":"7_CR16","unstructured":"Goal of the Diabetes Programme. World Health Organization 2009. Available at: http:\/\/www.who.int\/diabetes\/goal\/en\/index.html ."},{"key":"7_CR17","first-page":"1","volume-title":"Textbook of Diabetes","author":"H Yki-Jarvinen","year":"2003","unstructured":"Yki-Jarvinen H. Insulin resistance in type II diabetes. In: Pickup JC, Williams G, eds. Textbook of Diabetes. Oxford: Blackwell Publishing, 2003:22.1\u201322.19."},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","volume":"7","author":"MS Brown","year":"2008","unstructured":"Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008; 7:95\u201396.","journal-title":"Cell Metab"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/diabetes.54.4.917","volume":"54","author":"PA Tataranni","year":"2005","unstructured":"Tataranni PA, Ortega E. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 2005; 54:917\u2013927.","journal-title":"Diabetes"},{"key":"7_CR20","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796\u20131808.","journal-title":"J Clin Invest"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","volume":"115","author":"G Fantuzzi","year":"2005","unstructured":"Fantuzzi G. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol 2005; 115:911\u2013919.","journal-title":"J Allergy Clin Immunol"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444:860\u2013867.","journal-title":"Nature"},{"issue":"6","key":"7_CR23","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","volume":"132","author":"SE Shoelson","year":"2007","unstructured":"Shoelson SE, Herrero L, Naaz A. Obesity, inflammation and insulin resistance. Gastroenterology 2007; 132(6):2169\u20132180.","journal-title":"Gastroenterology"},{"issue":"9","key":"7_CR24","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.2337\/diacare.28.9.2312","volume":"28","author":"ZT Bloomgarden","year":"2005","unstructured":"Bloomgarden ZT. Inflammation, atherosclerosis and aspects of insulin action. Diabetes Care 2005; 28(9):2312\u20132319.","journal-title":"Diabetes Care"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000100426","volume":"68","author":"P Ferr\u00e9","year":"2007","unstructured":"Ferr\u00e9 P, Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res 2007; 68:72\u201382.","journal-title":"Horm Res"},{"key":"7_CR26","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109:1125\u20131131.","journal-title":"J Clin Invest"},{"key":"7_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1097-2765(05)00010-9","volume":"6","author":"I Shimomura","year":"2000","unstructured":"Shimomura I, Matsuda M, Hammer RE et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice. Mol Cell 2000; 6:77\u201386.","journal-title":"Mol Cell"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00125-009-1336-5","volume":"52","author":"MP Sajan","year":"2009","unstructured":"Sajan MP, Standaert MI, Rivas J et al. Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NF\u03baB) in liver of rodents used as a model of diabetes and relationships to hyperlipidaemia and insulin resistance. Diabetologia 2009; 52:1197\u20131207.","journal-title":"Diabetologia"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","volume":"53","author":"RH Unger","year":"2002","unstructured":"Unger RH. Lipotoxic diseases. Ann Rev Med 2002; 53:319\u2013336.","journal-title":"Ann Rev Med"},{"issue":"9","key":"7_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.tem.2003.09.008","volume":"14","author":"RH Unger","year":"2003","unstructured":"Unger RH. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003; 14(9):398\u2013403.","journal-title":"Trends Endocrinol Metab"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.biochem.75.103004.142512","volume":"75","author":"DM Muoio","year":"2006","unstructured":"Muoio DM, Newgard CB. Obesity-related derangements in metabolic regulation. Ann Rev Biochem 2006; 75:367\u2013401.","journal-title":"Ann Rev Biochem"},{"issue":"1","key":"7_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s001250051123","volume":"42","author":"M Krssak","year":"1999","unstructured":"Krssak M, Falk PK, Dresner A et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42(1):113\u2013116.","journal-title":"Diabetologia"},{"key":"7_CR33","doi-asserted-by":"crossref","unstructured":"Chavez JA, Summers SA. Lipid oversupply, selective insulin resistance and lipotoxicity: Molecular mechanisms. Biochim Biophys Acta 2009 [Epub ahead of print].","DOI":"10.1016\/j.bbalip.2009.09.015"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1172\/JCI30400","volume":"117","author":"VT Samuel","year":"2007","unstructured":"Samuel VT, Liu ZX, Wang A et al. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 2007; 117:739\u2013745.","journal-title":"J Clin Invest"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"50230","DOI":"10.1074\/jbc.M200958200","volume":"277","author":"C Yu","year":"2002","unstructured":"Yu C, Chen Y, Zong H et al. Mechanism by which fatty acids inhibit insulin activation of IRS-1 associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277:50230\u201350236.","journal-title":"J Biol Chem"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s00125-007-0709-x","volume":"50","author":"R Cazzolli","year":"2007","unstructured":"Cazzolli R, Mitchell TW, Burchfield JG et al. Dilinoleoyl-phosphatidic acid mediates reduced IRS-1 tyrosine phosphorylation in rat skeletal muscle cells and mouse muscle. Diabetologia 2007; 50:1732\u20131742.","journal-title":"Diabetologia"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature04634","volume":"440","author":"N Houstis","year":"2008","unstructured":"Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2008; 440:944\u2013948.","journal-title":"Nature"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cmet.2008.04.005","volume":"7","author":"KL Hoehn","year":"2008","unstructured":"Hoehn KL, Hohnen-Behrens C, Cederberg A et al. IRS 1-independent defects define major nodes of insulin resistance. Cell Metab 2008; 7:421\u2013433.","journal-title":"Cell Metab"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"17787","DOI":"10.1073\/pnas.0902380106","volume":"106","author":"KL Hoehn","year":"2009","unstructured":"Hoehn KL, Salmon AB, Hohnen-Behrens C et al. Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci USA 2009; 106:17787\u201317792.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/0957154X0101204702","volume":"12","author":"CS Breathnach","year":"2001","unstructured":"Breathnach CS. Johann Ludwig Wilhelm Thudichum 1829\u20131901, bane of the Protagonisers. Hist Psychiatry 2001; 12:283\u2013296.","journal-title":"Hist Psychiatry"},{"key":"7_CR41","volume-title":"A Treatise on the Chemical Constitution of the Brain","author":"JLWI Thudichum","year":"1884","unstructured":"Thudichum JLW. In: A Treatise on the Chemical Constitution of the Brain, Bailli\u00e8re,Tindall and Cox, London, 1884."},{"key":"7_CR42","volume-title":"The Life and Work of Thudichum JLW, 1829\u20131901: A Most Celebrated Exponent of the Art of Medicine and Chemistry","author":"TLI Sourkes","year":"2003","unstructured":"Sourkes TL. In: The Life and Work of Thudichum JLW, 1829\u20131901: A Most Celebrated Exponent of the Art of Medicine and Chemistry. Montreal: McGill University, 2003."},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.tibs.2007.09.004","volume":"32","author":"AH Merrill Jr","year":"2007","unstructured":"Merrill AH Jr, Wang MD, Park M et al. (Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology. Trends Biochem Sci 2007; 32:457\u2013468.","journal-title":"Trends Biochem Sci"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"D527","DOI":"10.1093\/nar\/gkl838","volume":"35","author":"M Sud","year":"2007","unstructured":"Sud M, Fahy E, Cotter D et al. LMSD: LIPID MAPS structure database. Nucleic acids Res 2007; 35(Database issue):D527\u2013D532.","journal-title":"Nucleic acids Res"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.bbamem.2006.08.004","volume":"1758","author":"AH Futerman","year":"2006","unstructured":"Futerman AH. Intracellular trafficking of sphingolipids: relationship to biosynthesis. Biochim Biophys Acta 2006; 1758:1885\u20131892.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2005.04.006","volume":"15","author":"AH Futerman","year":"2005","unstructured":"Futerman AH, Riezman H. The ins and outs of sphingolipid synthesis. Trends Cell Biol 2005; 15:312\u2013318.","journal-title":"Trends Cell Biol"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bbamcr.2008.09.020","volume":"1793","author":"H Schulze","year":"2009","unstructured":"Schulze H, Kolter T, Sandhoff K. Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation. Biochim Biophys Acta 2009; 1793:674\u2013683.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","volume":"64","author":"S Lahiri","year":"2007","unstructured":"Lahiri S, Futerman AH. The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci 2007; 64:2270\u20132284.","journal-title":"Cell Mol Life Sci"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1006\/taap.1996.8029","volume":"142","author":"AH Merrill Jr","year":"1997","unstructured":"Merrill AH jr, Schmelz EM, Dillehay DL et al. Sphingolipids-the enigmatic lipid class: biochemistry, physiology and pathophysiology. Toxicol Appl Pharmacol 1997; 142:208\u2013225.","journal-title":"Toxicol Appl Pharmacol"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","volume":"20","author":"K Kitatani","year":"2008","unstructured":"Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 2008; 20:1010\u20131018.","journal-title":"Cell Signal"},{"key":"7_CR51","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbalip.2007.04.004","volume":"1771","author":"MA Matteis De","year":"2007","unstructured":"De Matteis MA, Di Campli A, D\u2019Angelo G. Lipid-transfer proteins in membrane trafficking at the Golgi complex. Biochim Biophys Acta 2007; 1771:761\u2013768.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nature02188","volume":"426","author":"K Hanada","year":"2003","unstructured":"Hanada K, Kumagai K, Yasuda S et al. Molecular machinery for nonvesicular trafficking of ceramide. Nature 2003; 426:803\u2013809.","journal-title":"Nature"},{"key":"7_CR53","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbalip.2009.01.006","volume":"1791","author":"K Hanada","year":"2009","unstructured":"Hanada K, Kumagai K, Tomishige N et al. CERT-mediated trafficking of ceramide. Biochim Biophys Acta 2009; 1791:684\u2013691.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1006\/geno.1996.0242","volume":"34","author":"A Bosio","year":"1996","unstructured":"Bosio A, Binczek E, Le Beau MM et al. The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization and assignment to human chromosome 4, band q26. Genomics 1996; 34:69\u201375.","journal-title":"Genomics"},{"key":"7_CR55","first-page":"40","volume":"1781","author":"P Giussani","year":"2008","unstructured":"Giussani P, Colleoni T, Brioschi L et al. Ceramide traffic in C6 glioma cells: evidence for CERT-dependent and independent transport from ER to the Golgi apparatus. Biochim Biophys Acta 2008; 1781:40\u201351.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1042\/BJ20021834","volume":"371","author":"D Ardail","year":"2003","unstructured":"Ardail D, Popa I, Bodennec J et al. The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases. Biochem J 2003;371(Pt3):1013\u20131019.","journal-title":"Biochem J"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0005-2736(85)90412-2","volume":"814","author":"H Coste","year":"1985","unstructured":"Coste H, Martel MB, Azzar G et al. UDP glucose-ceramide glucosyltransferase from porcine submaxillary glands is associated with the Golgi apparatus. Biochem Biophys Acta 1985; 814:1\u20137.","journal-title":"Biochem Biophys Acta"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"12654","DOI":"10.1073\/pnas.93.10.4638","volume":"93","author":"S Ichikawa","year":"1996","unstructured":"Ichikawa S, Sakiyama H, Suzuki G et al. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the First glycosylation step of glycosphingolipid synthesis. Proc Natl Acad Sci USA 1996; 93:12654.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0962-8924(98)01249-5","volume":"8","author":"S Ichikawa","year":"1998","unstructured":"Ichikawa S, Hirabayashi Y. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol 1998; 8:198\u2013202.","journal-title":"Trends Cell Biol"},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1021\/bi020385t","volume":"41","author":"X Buton","year":"2002","unstructured":"Buton X, Herv\u00e9 P, Kubelt J et al. Transbilayer movement of monohexosylsphingolipids in endoplasmic reticulum and Golgi membranes. Biochemistry 2002; 41:13106\u201313115.","journal-title":"Biochemistry"},{"key":"7_CR61","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1042\/BJ20050047","volume":"389","author":"PD Eckford","year":"2005","unstructured":"Eckford PD, Sharom FJ. The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids. Biochem J 2005; 389(Pt 2):517\u2013526.","journal-title":"Biochem J"},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature06097","volume":"449","author":"G D\u2019Angelo","year":"2007","unstructured":"D\u2019Angelo G, Polishchuk E, Di Tullio G et al. Glycosphingolipid synthesis requiRes FAPP2 transfer of glucosylceramide. Nature 2007; 449:62\u201367.","journal-title":"Nature"},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrm2378","volume":"9","author":"MA Matteis De","year":"2008","unstructured":"De Matteis MA, Luini A. Exiting the Golgi complex. Nat Rev Mol Cell Biol 2008; 9:273\u2013284.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1083\/jcb.200704091","volume":"179","author":"D Halter","year":"2007","unstructured":"Halter D, Neumann S, van Dijk SM et al. Pre-and postGolgi translocation of glucosylceramide in glycosphingolipid synthesis. J Cell Biol 2007; 179:101\u2013115.","journal-title":"J Cell Biol"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1515\/BC.2008.154","volume":"389","author":"S Neumann","year":"2008","unstructured":"Neumann S, van Meer G. Sphingolipid management by an orchestra of lipid transfer proteins. Biol Chem 2008; 389:1349\u20131360.","journal-title":"Biol Chem"},{"key":"7_CR66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-2275(20)40231-7","volume":"5","author":"L Svennerholm","year":"1964","unstructured":"Svennerholm L. The gangliosides. J Lipid Res 1964; 5:145\u2013155.","journal-title":"J Lipid Res"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"25859","DOI":"10.1074\/jbc.R200001200","volume":"277","author":"T Kolter","year":"2002","unstructured":"Kolter T, Proia RL, Sandhoff K. Combinatorial ganglioside biosynthesis. J Biol Chem 2002; 277:25859\u201325862.","journal-title":"J Biol Chem"},{"key":"7_CR68","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bbamcr.2008.09.020","volume":"1793","author":"H Schulze","year":"2009","unstructured":"Schulze H, Kolter T, Sandhoff K. Principles of lysosomal membrane degradation: Cellular topology and biochemistry of lysosomal lipid degradation. Biochim Biophys Acta 2009; 1793:674\u2013683.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/BF00710267","volume":"16","author":"JM Aerts","year":"1993","unstructured":"Aerts JM, van Weely S, Boot R et al. Pathogenesis of lysosomal storage disorders as illustrated by Gaucher disease. J Inherit Metab Dis 1993; 16:288\u2013291.","journal-title":"J Inherit Metab Dis"},{"key":"7_CR70","doi-asserted-by":"crossref","first-page":"10975","DOI":"10.1016\/S0021-9258(19)78077-6","volume":"269","author":"S Miao","year":"1994","unstructured":"Miao S, McCarter JD, Grace ME et al. Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry. J Biol Chem 1994; 269:10975\u201310978.","journal-title":"J Biol Chem"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/sj.embor.embor873","volume":"4","author":"H Dvir","year":"2003","unstructured":"Dvir H, Harel M, McCarthy AA et al. X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep 2003; 4:704\u2013709.","journal-title":"EMBO Rep"},{"key":"7_CR72","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.str.2008.02.016","volume":"16","author":"M Rossmann","year":"2008","unstructured":"Rossmann M, Schultz-Heienbrok R, Behlke J et al. Crystal structures of human saposins C and D: implications for lipid recognition and membrane interactions. Structure 2008; 16:809\u2013817.","journal-title":"Structure"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/jcb.20097","volume":"92","author":"H Stunff Le","year":"2004","unstructured":"Le Stunff H, Milstien S, Spiegel S. Generation and metabolism of bioactive sphingosine-1-phosphate. J Cell Biochem 2004; 92:882\u2013899.","journal-title":"J Cell Biochem"},{"key":"7_CR74","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj2700815","volume":"270","author":"M Trinchera","year":"1990","unstructured":"Trinchera M, Ghidoni R, Sonnino S et al. Recycling of glucosylceramide and sphingosine for the biosynthesis of gangliosides and sphingomyelin in rat liver. Biochem J 1990; 270:815\u2013820.","journal-title":"Biochem J"},{"issue":"Suppl. 1","key":"7_CR75","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1471-4159.2007.04714.x","volume":"103","author":"A Prinetti","year":"2007","unstructured":"Prinetti A, Chigorno V, Mauri L et al. Modulation of cell functions by glycosphingolipid metabolic remodeling in the plasma membrane. J Neurochem 2007; 103(Suppl. 1):113\u2013125.","journal-title":"J Neurochem"},{"key":"7_CR76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0925-4439(93)90090-N","volume":"1181","author":"S Weely van","year":"1993","unstructured":"van Weely S, Brandsma M, Strijland A et al. Demonstration of the existence of a second, nonlysosomal glucocerebrosidase that is not deficient in Gaucher disease. Biochim Biophys Acta 1993; 1181:55\u201362.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"7_CR77","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1074\/jbc.M610544200","volume":"282","author":"RG Boot","year":"2007","unstructured":"Boot RG, Verhoek M, Donker-Koopman W et al. Identification of the nonlysosomal glucosylceramidase as beta-glucosidase 2. J Biol Chem 2007; 282(2):1305\u20131312.","journal-title":"J Biol Chem"},{"key":"7_CR78","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1172\/JCI29224","volume":"116","author":"Y Yildiz","year":"2008","unstructured":"Yildiz Y, Matern H, Thompson B et al. Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility. J Clin Invest 2008; 116:2985\u20132994.","journal-title":"J Clin Invest"},{"key":"7_CR79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1463-1326.2006.00701.x","volume":"10","author":"DA Priestman","year":"2008","unstructured":"Priestman DA, van der Spoel AC, Butters TD et al. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice. Diabetes Obes Metab 2008; 10:159\u2013166.","journal-title":"Diabetes Obes Metab"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"32655","DOI":"10.1074\/jbc.M702387200","volume":"282","author":"CM Walden","year":"2007","unstructured":"Walden CM, Sandhoff R, Chuang CC et al. Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis. J Biol Chem 2007; 282:32655\u201332664.","journal-title":"J Biol Chem"},{"key":"7_CR81","first-page":"3635","volume-title":"The Metabolic and Molecular Basis of Inherited Diseases","author":"E Beutler","year":"2001","unstructured":"Beutler E, Grabowski GA. In: Scriver CR et al eds. The Metabolic and Molecular Basis of Inherited Diseases. New York: McGraw-Hill, 2001:3635\u20133668."},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0009-8981(86)90231-7","volume":"158","author":"JM Aerts","year":"1986","unstructured":"Aerts JM, Donker-Koopman WE, Koot M et al. Deficient activity of glucocerebrosidase in urine from patients with type 1 Gaucher disease. Clin Chim Acta 1986; 158:155\u2013163.","journal-title":"Clin Chim Acta"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1432-1033.1985.tb09058.x","volume":"150","author":"JM Aerts","year":"1985","unstructured":"Aerts JM, Donker-Koopman WE, van der Vliet MK et al. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen. Eur J Biochem 1985; 150:565\u2013574.","journal-title":"Eur J Biochem"},{"key":"7_CR84","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1432-1033.1987.tb11008.x","volume":"164","author":"LM Jonsson","year":"1987","unstructured":"Jonsson LM, Murray GJ, Sorrell SH et al. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts. Eur J Biochem 1987; 164:171\u2013179.","journal-title":"Eur J Biochem"},{"key":"7_CR85","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0925-4439(91)90066-I","volume":"1096","author":"S Weely Van","year":"1991","unstructured":"Van Weely S, Van Leeuwen MB, Jansen ID et al. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts. Biochim Biophys Acta 1991; 1096:301\u2013311.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR86","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/S0021-9258(19)67845-2","volume":"266","author":"T Ohashi","year":"1991","unstructured":"Ohashi T, Hong CM, Weiler S et al. Characterization of human glucocerebrosidase from different mutant alleles. J Biol Chem 1991; 266:3661\u20133667.","journal-title":"J Biol Chem"},{"key":"7_CR87","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI116276","volume":"91","author":"S Weely van","year":"1993","unstructured":"van Weely S, van den Berg M, Barranger JA et al. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease. J Clin Invest 1993; 91:1167\u20131175.","journal-title":"J Clin Invest"},{"key":"7_CR88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0304-4165(88)90030-X","volume":"964","author":"JM Aerts","year":"1988","unstructured":"Aerts JM, Schram AW, Strijland A et al. Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation. Biochim Biophys Acta 1988; 964:303\u2013308.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR89","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","volume":"131","author":"D Reczek","year":"2007","unstructured":"Reczek D, Schwake M, Schr\u00f6der J et al. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 2007; 131:770\u2013783.","journal-title":"Cell"},{"key":"7_CR90","doi-asserted-by":"crossref","unstructured":"Blanz J, Groth J, Zachos C et al. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand ta-glucocerebrosidase. Hum Mol Genet 2009 [Epub ahead of print].","DOI":"10.1093\/hmg\/ddp523"},{"key":"7_CR91","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1093\/hmg\/ddn124","volume":"17","author":"A Balreira","year":"2008","unstructured":"Balreira A, Gaspar P, Caiola D et al. A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome. Hum Mol Genet 2008; 17:2238\u20132243.","journal-title":"Hum Mol Genet"},{"key":"7_CR92","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","volume":"72","author":"A Tylki-Szymanska","year":"2007","unstructured":"Tylki-Szymanska A, Czartoryska B, Vanier MT et al. Non-neuronopathic Gaucher disease due to saposin C deficiency. Clin Genet 2007; 72:538\u2013542.","journal-title":"Clin Genet"},{"key":"7_CR93","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","volume":"103","author":"RG Boot","year":"2004","unstructured":"Boot RG, Verhoek M, de Fost M et al. Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 2004; 103:33\u201339.","journal-title":"Blood"},{"key":"7_CR94","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI117084","volume":"93","author":"CE Hollak","year":"1994","unstructured":"Hollak CE, van Weely S, van Oers MH et al. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 1994; 93:1288\u20131292.","journal-title":"J Clin Invest"},{"key":"7_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/08035320510028094","volume":"94","author":"JM Aerts","year":"2005","unstructured":"Aerts JM, Hollak CE, van Breemen M et al. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases. Acta Paediatr Suppl 2005; 94:43\u201346.","journal-title":"Acta Paediatr Suppl"},{"key":"7_CR96","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","volume":"122","author":"LA Boven","year":"2004","unstructured":"Boven LA, van Meurs M, Boot RG et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol 2004; 122:359\u2013369.","journal-title":"Am J Clin Pathol"},{"key":"7_CR97","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0962-8924(99)01694-3","volume":"10","author":"YA Hannun","year":"2000","unstructured":"Hannun YA, Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol 2000; 10:73\u201380.","journal-title":"Trends Cell Biol"},{"key":"7_CR98","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1210\/en.2003-0870","volume":"144","author":"RH Unger","year":"2003","unstructured":"Unger RH: Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144:5159\u20135165.","journal-title":"Endocrinology"},{"key":"7_CR99","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","volume":"45","author":"SA Summers","year":"2006","unstructured":"Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006; 45:42\u201372.","journal-title":"Prog Lipid Res"},{"key":"7_CR100","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1301\/nr.2007.jun.S39-S46","volume":"65","author":"WL Holland","year":"2007","unstructured":"Holland WL, Knotts TA, Chavez JA et al. Lipid mediators of insulin resistance. Nutr Rev 2007; 65: S39\u2013S46.","journal-title":"Nutr Rev"},{"key":"7_CR101","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1210\/er.2007-0025","volume":"29","author":"WL Holland","year":"2008","unstructured":"Holland WL, Summers SA. Sphingolipids, insulin resistance and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 2008; 29:381\u2013402.","journal-title":"Endocr Rev"},{"key":"7_CR102","doi-asserted-by":"publisher","first-page":"24202","DOI":"10.1074\/jbc.274.34.24202","volume":"274","author":"C Schmitz-Peiffer","year":"1999","unstructured":"Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999; 274:24202\u201324210.","journal-title":"J Biol Chem"},{"key":"7_CR103","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jcp.20922","volume":"211","author":"MA Sabin","year":"2007","unstructured":"Sabin MA, Stewart CE, Crowne EC et al. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. J Cell Physiol 2007; 211:244\u2013252.","journal-title":"J Cell Physiol"},{"key":"7_CR104","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.1074\/jbc.M212307200","volume":"278","author":"JA Chavez","year":"2003","unstructured":"Chavez JA, Knotts TA, Wang LP et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278:10297\u201310303.","journal-title":"J Biol Chem"},{"key":"7_CR105","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1042\/BJ20040139","volume":"382","author":"DJ Powell","year":"2004","unstructured":"Powell DJ, Turban S, Gray A et al. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat l6 skeletal muscle cells. Biochem J 2004; 382:619\u2013629.","journal-title":"Biochem J"},{"key":"7_CR106","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.1074\/jbc.M611157200","volume":"282","author":"L Pickersgill","year":"2007","unstructured":"Pickersgill L, Litherland GJ, Greenberg AS et al. Key role for ceramides in mediating insulin resistance in human muscle cells. J Biol Chem 2007; 282:12583\u201312589.","journal-title":"J Biol Chem"},{"key":"7_CR107","doi-asserted-by":"publisher","first-page":"20148","DOI":"10.1074\/jbc.M412769200","volume":"280","author":"JA Chavez","year":"2005","unstructured":"Chavez JA, Holland WL, Bar J et al. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem 2005; 280:20148\u201320153.","journal-title":"J Biol Chem"},{"key":"7_CR108","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ijo.0802183","volume":"27","author":"J Mei","year":"2003","unstructured":"Mei J, Wang CN, O\u2019Brien L et al. Cell-permeable ceramides increase basal glucose incorporation into triacylglycerols but decrease the stimulation by insulin in 3T3-L1 adipocytes. Int J Obes Relat Metab Disord 2003; 27:31\u201339.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"7_CR109","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1128\/MCB.18.9.5457","volume":"18","author":"SA Summers","year":"1998","unstructured":"Summers SA, Garza LA, Zhou H et al. Regulation of insulin stimulated glucose transporter GLUT4 translocation and akt kinase activity by ceramide. Mol Cell Biol 1998; 18:5457\u20135464.","journal-title":"Mol Cell Biol"},{"key":"7_CR110","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1007\/BF02562240","volume":"34","author":"DN Brindley","year":"1999","unstructured":"Brindley DN, Wang CN, Mei J et al. Tumor necrosis factor-alpha and ceramides in insulin resistance. Lipids 1999; 34:S85\u2013S88.","journal-title":"Lipids"},{"key":"7_CR111","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/bj3190179","volume":"319","author":"SD Long","year":"1996","unstructured":"Long SD, Pekala PH. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem J 1996; 319:179\u2013184.","journal-title":"Biochem J"},{"key":"7_CR112","doi-asserted-by":"publisher","first-page":"33615","DOI":"10.1074\/jbc.M406499200","volume":"279","author":"S Stratford","year":"2004","unstructured":"Stratford S, Hoehn KL, Liu F et al. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B. J Biol Chem 2004; 279:33615\u201336608.","journal-title":"J Biol Chem"},{"key":"7_CR113","doi-asserted-by":"crossref","first-page":"16880","DOI":"10.1016\/S0021-9258(17)44844-7","volume":"265","author":"J Turinsky","year":"1990","unstructured":"Turinsky J, O\u2019Sullivan DM, Bayly BP. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 1990; 265:16880\u201316885.","journal-title":"J Biol Chem"},{"key":"7_CR114","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","volume":"5","author":"WL Holland","year":"2007","unstructured":"Holland WL, Brozinick JT, Wang LP et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-and obesity-induced insulin resistance. Cell Metab 2007; 5:167\u2013179.","journal-title":"Cell Metab"},{"key":"7_CR115","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.plipres.2009.03.002","volume":"48","author":"M Langeveld","year":"2009","unstructured":"Langeveld M, Aerts JM. Glycosphingolipids and insulin resistance. Prog Lipid Res 2009; 48:196\u2013205.","journal-title":"Prog Lipid Res"},{"key":"7_CR116","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1152\/japplphysiol.01438.2005","volume":"100","author":"JS Lee","year":"2006","unstructured":"Lee JS, Pinnamaneni SK, Eo SJ et al. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 2006; 100:1467\u20131474.","journal-title":"J Appl Physiol"},{"key":"7_CR117","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2337\/db06-0719","volume":"56","author":"H Zhao","year":"2007","unstructured":"Zhao H, Przybylska M, Wu IH et al. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes 2007; 56:1210\u20131218.","journal-title":"Diabetes"},{"key":"7_CR118","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2337\/diabetes.53.1.25","volume":"53","author":"JM Adams","year":"2004","unstructured":"Adams JM, Pratipanawatr T, Berria R et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004; 53:25\u201331.","journal-title":"Diabetes"},{"key":"7_CR119","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1007\/s00125-007-0781-2","volume":"50","author":"M Straczkowski","year":"2007","unstructured":"Straczkowski M, Kowalska I, Baranowski M et al. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 2007; 50:2366\u20132373.","journal-title":"Diabetologia"},{"key":"7_CR120","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00125-008-1014-z","volume":"51","author":"M Skovbro","year":"2008","unstructured":"Skovbro M, Baranowski M, Skov-Jensen C et al. Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia 2008;51:1253\u20131260.","journal-title":"Diabetologia"},{"key":"7_CR121","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2337\/diabetes.53.5.1215","volume":"53","author":"M Straczkowski","year":"2004","unstructured":"Straczkowski M, Kowalska I, Nikolajuk A et al. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004; 53:1215\u20131221.","journal-title":"Diabetes"},{"key":"7_CR122","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1210\/jc.2006-2347","volume":"92","author":"MJ Serlie","year":"2007","unstructured":"Serlie MJ, Meijer AJ, Groener JE et al. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab 2007; 92:1524\u20131529.","journal-title":"J Clin Endocrinol Metab"},{"key":"7_CR123","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbalip.2005.08.006","volume":"1737","author":"MR Hojjati","year":"2005","unstructured":"Hojjati MR, Li Z, Jiang XC. Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. Biochim Biophys Acta 2005; 1737:44\u201351.","journal-title":"Biochim Biophys Acta"},{"key":"7_CR124","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1016\/S0021-9258(20)64355-1","volume":"266","author":"H Nojiri","year":"1991","unstructured":"Nojiri H, Stroud M, Hakomori S. A specific type of ganglioside as a modulator of insulin-dependent cell growth and insulin receptor tyrosine kinase activity. Possible association of ganglioside-induced inhibition of insulin receptor function and monocytic differentiation induction in HL-60 cells. J Biol Chem 1991; 266:4531\u20134537.","journal-title":"J Biol Chem"},{"key":"7_CR125","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1074\/jbc.M103705200","volume":"277","author":"S Tagami","year":"2002","unstructured":"Tagami S, Inokuchi JJ, Kabayama K et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem 2002; 277:3085\u20133092.","journal-title":"J Biol Chem"},{"key":"7_CR126","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/glycob\/cwh135","volume":"15","author":"K Kabayama","year":"2005","unstructured":"Kabayama K, Sato T, Kitamura F et al. TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 2005; 15:21\u201329.","journal-title":"Glycobiology"},{"key":"7_CR127","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1073\/pnas.0635898100","volume":"100","author":"T Yamashita","year":"2003","unstructured":"Yamashita T, Hashiramoto A, Haluzik M et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA 2003; 100:3445\u20133449.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR128","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.metabol.2006.10.027","volume":"56","author":"S Yoshizumi","year":"2007","unstructured":"Yoshizumi S, Suzuki S, Hirai M et al. Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice. Metabolism 2007; 56:420\u2013429.","journal-title":"Metabolism"},{"key":"7_CR129","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.2337\/db06-0539","volume":"55","author":"TE Fox","year":"2006","unstructured":"Fox TE, Han X, Kelly S et al. Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy. Diabetes 2006; 55:3573\u20133580.","journal-title":"Diabetes"},{"key":"7_CR130","doi-asserted-by":"publisher","first-page":"13678","DOI":"10.1073\/pnas.0703650104","volume":"104","author":"K Kabayama","year":"2007","unstructured":"Kabayama K, Sato T, Saito K et al. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci USA 2007; 104:13678\u201313683.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR131","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1210\/jc.80.9.2653","volume":"80","author":"EP Corssmit","year":"1995","unstructured":"Corssmit EP, Hollak CE, Endert E et al. Increased basal glucose production in type 1 Gaucher\u2019s disease. J Clin Endocrinol Metab 1995; 80:2653\u20132657.","journal-title":"J Clin Endocrinol Metab"},{"key":"7_CR132","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0002-9343(97)00134-4","volume":"103","author":"CE Hollak","year":"1997","unstructured":"Hollak CE, Corssmit EP, Aerts JM et al. Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease. Am J Med 1997; 103:185\u2013191.","journal-title":"Am J Med"},{"key":"7_CR133","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.metabol.2006.10.014","volume":"56","author":"M Langeveld","year":"2007","unstructured":"Langeveld M, Scheij S, Dubbelhuis P et al. Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia. Metabolism 2007; 56:314\u2013319.","journal-title":"Metabolism"},{"key":"7_CR134","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1210\/jc.2007-1702","volume":"93","author":"M Langeveld","year":"2008","unstructured":"Langeveld M, Ghauharali KJ, Sauerwein HP et al. Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. J Clin Endocrinol Metab 2008; 93:845\u2013851.","journal-title":"J Clin Endocrinol Metab"},{"key":"7_CR135","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cca.2007.12.001","volume":"389","author":"K Ghauharali-van der Vlugt","year":"2008","unstructured":"Ghauharali-van der Vlugt K, Langeveld M, Poppema A et al. Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. Clin Chim Acta 2008; 389:109\u2013113.","journal-title":"Clin Chim Acta"},{"key":"7_CR136","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bcmd.2007.09.002","volume":"40","author":"M Langeveld","year":"2008","unstructured":"Langeveld M, de Fost M, Aerts JM et al. Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy. Blood cells Mol Dis 2008; 40:428\u2013432.","journal-title":"Blood cells Mol Dis"},{"key":"7_CR137","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ymgme.2008.10.001","volume":"96","author":"SK Ucar","year":"2009","unstructured":"Ucar SK, Coker M, Argin M et al. A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweight. Mol Genet Metab 2009; 96:50\u201351.","journal-title":"Mol Genet Metab"},{"key":"7_CR138","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","volume":"29","author":"JM Aerts","year":"2006","unstructured":"Aerts JM, Hollak CE, Boot RG et al. Substrate reduction therapy of glycosphingolipid storage disorders. J Inherit Metab Dis 2006; 29:449\u2013456.","journal-title":"J Inherit Metab Dis"},{"key":"7_CR139","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","volume":"269","author":"FM Platt","year":"1994","unstructured":"Platt FM, Neises GR, Dwek RA et al. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biol Chem 1994; 269:8362\u20138365.","journal-title":"J Biol Chem"},{"key":"7_CR140","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","volume":"355","author":"T Cox","year":"2000","unstructured":"Cox T, Lachmann R, Hollak C et al. Novel oral treatment of Gaucher\u2019s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 2000; 355:1481\u20131485.","journal-title":"Lancet"},{"issue":"7","key":"7_CR141","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1182\/blood-2007-02-075960","volume":"110","author":"D Elstein","year":"2007","unstructured":"Elstein D, Dweck A, Attias D et al. Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement. Blood 2007; 110(7):2296\u20132301.","journal-title":"Blood"},{"key":"7_CR142","doi-asserted-by":"publisher","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","volume":"273","author":"HS Overkleeft","year":"1998","unstructured":"Overkleeft HS, Renkema GH, Neele J et al. Generation of specific deoxynojirimycin-type inhibitors of the nonlysosomal glucosylceramidase. J Biol Chem 1998; 273:26522\u201326527.","journal-title":"J Biol Chem"},{"key":"7_CR143","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2337\/db06-1619","volume":"56","author":"JM Aerts","year":"2007","unstructured":"Aerts JM, Ottenhoff R, Powlson AS et al. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes 2007; 56:1341\u20131349.","journal-title":"Diabetes"},{"key":"7_CR144","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1021\/jo061280p","volume":"72","author":"T Wennekes","year":"2007","unstructured":"Wennekes T, van den Berg RJ, Donker W et al. Development of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man. J Org Chem 2007; 72:1088\u20131097.","journal-title":"J Org Chem"},{"key":"7_CR145","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1002\/anie.200902620","volume":"48","author":"T Wennekes","year":"2009","unstructured":"Wennekes T, van den Berg RJ, Boot RG et al. Glycosphingolipids\u2014nature, function and pharmacological modulation. Angew Chem Int Ed Engl 2009; 48:8848\u20138869.","journal-title":"Angew Chem Int Ed Engl"},{"key":"7_CR146","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ymgme.2007.04.001","volume":"91","author":"KA McEachern","year":"2007","unstructured":"McEachern KA, Fung J, Komarnitsky S et al. A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. Mol Genet Metab 2007; 91:259\u2013267.","journal-title":"Mol Genet Metab"},{"key":"7_CR147","doi-asserted-by":"crossref","unstructured":"Wennekes T Meijer AJ, Groen AK et al. Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation. J Med Chem 2009 [In press]","DOI":"10.1021\/jm901281m"},{"key":"7_CR148","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.intimp.2004.04.008","volume":"4","author":"C Shen","year":"2004","unstructured":"Shen C, Bullens D, Kasran A et al. Inhibition of glycolipid biosynthesis by N-(5-adamantane-l-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis. Int Immunopharmacol 2004; 4:939\u2013951.","journal-title":"Int Immunopharmacol"},{"key":"7_CR149","doi-asserted-by":"publisher","first-page":"e4723","DOI":"10.1371\/journal.pone.0004723","volume":"4","author":"M Eijk van","year":"2009","unstructured":"van Eijk M, Aten J, Bijl N et al. Reducing glycosphingolipid content in adipose tissue of obese mice restoRes insulin sensitivity, adipogenesis and reduces inflammation. PLoS One 2009; 4:e4723.","journal-title":"PLoS One"},{"key":"7_CR150","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/hep.23175","volume":"50","author":"N Bijl","year":"2009","unstructured":"Bijl N, Sokolovi\u0107 M, Vrins C et al. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. Hepatology 2009; 50:1431\u20131441.","journal-title":"Hepatology"},{"key":"7_CR151","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/hep.22663","volume":"49","author":"N Bijl","year":"2009","unstructured":"Bijl N, van Roomen CP, Triantis V et al. Reduction of glycosphingolipid biosynthesis stimulates biliary lipid secretion in mice. Hepatology 2009; 49:637\u2013645.","journal-title":"Hepatology"},{"key":"7_CR152","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/hep.22970","volume":"50","author":"H Zhao","year":"2009","unstructured":"Zhao H, Przybylska M, Wu IH et al. Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice. Hepatology 2009; 50:85\u201393.","journal-title":"Hepatology"}],"container-title":["Advances in Experimental Medicine and Biology","Sphingolipids and Metabolic Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-0650-1_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T07:43:25Z","timestamp":1712821405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-0650-1_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9781461406495","9781461406501"],"references-count":152,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-0650-1_7","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}